overactive thyroid

Trials

40 participants · First posted Nov 30, 2020

Recruiting

NCT06345339

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

2,800 participants · First posted Apr 3, 2024

Not yet recruiting

NCT07627529

Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease

20 participants · First posted Jun 4, 2026

Drugs

View all 59 →

Biotech

Approved

Thyroid, porcine

Conditions: Hypothyroidism

Armour Thyroid

thyroid hormone

Organizations

View all 8 →

Rare Thyroid Therapeutics International AB

Sweden

Veracyte

United States

AbbVie Inc.

United States

News

View all 528 →

yesterday

FDA Elevates Vitruvias Thyroid Tablet Recall to Class I Over Superpotency Risk

25 days ago

Eli Lilly to Acquire Merida Biosciences for Up to $2.88 Billion, Adding Novel Autoantibody-Targeting Pipeline

2 years ago

Trials

Comparison of TOETVA and Conventional Thyroidectomy

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease

Drugs

Thyroid, porcine

Armour Thyroid

thyroid hormone

Organizations

Rare Thyroid Therapeutics International AB

Veracyte

AbbVie Inc.

News

FDA Elevates Vitruvias Thyroid Tablet Recall to Class I Over Superpotency Risk

Eli Lilly to Acquire Merida Biosciences for Up to $2.88 Billion, Adding Novel Autoantibody-Targeting Pipeline

Immunovant's Batoclimab Shows Promise in Graves' Disease Phase II Trial; IMVT-1402 Pivotal Trial Planned